首页> 外国专利> Predictive test method for drug-induced proteinuria and human leukocyte antigen marker for predictive testing

Predictive test method for drug-induced proteinuria and human leukocyte antigen marker for predictive testing

机译:药物性蛋白尿的预测测试方法和用于预测测试的人类白细胞抗原标记

摘要

PROBLEM TO BE SOLVED: To provide an inspection method capable of accurately predicting drug-induced albuminuria.SOLUTION: HLA-DRB1*08:02 which is a human leukocyte antigen, or DQB1*04:02 is detected. Drugs causing drug induction are bucillamine, sodium aurothiomalate, D-penicillamine, etc. Albuminuria is albuminuria accompanying articular rheumatism. A patient who is determined that possibility of onset of albuminuria is high has an opportunity to select and determine medication and treatment policy which hardly induce albuminuria.
机译:解决的问题:提供一种能够准确预测药物诱导的蛋白尿的检查方法。解决方案:检测到人类白细胞抗原HLA-DRB1 * 08:02或DQB1 * 04:02。引起药物诱导的药物是布西拉明,金硫代苹果酸钠,D-青霉胺等。白蛋白尿是伴随风湿病的白蛋白尿。确定白蛋白尿发作可能性高的患者,有机会选择和确定几乎不会诱发白蛋白尿的药物和治疗策略。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号